Diphenhydramine/lidocaine/nystatin topical Interactions
There are 53 drugs known to interact with diphenhydramine/lidocaine/nystatin topical, along with 5 disease interactions. Of the total drug interactions, 4 are major, 47 are moderate, and 2 are minor.
- View all 53 medications that may interact with diphenhydramine/lidocaine/nystatin topical
- View diphenhydramine/lidocaine/nystatin topical disease interactions (5)
Most frequently checked interactions
View interaction reports for diphenhydramine / lidocaine / nystatin topical and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- Allegra (fexofenadine)
- Aricept (donepezil)
- Bactrim (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- Carafate (sucralfate)
- Celexa (citalopram)
- Compazine (prochlorperazine)
- CoQ10 (ubiquinone)
- Depo Provera (medroxyprogesterone)
- Dexilant (dexlansoprazole)
- Eliquis (apixaban)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flexeril (cyclobenzaprine)
- Ipratropium Inhalation Solution (ipratropium)
- Lyrica (pregabalin)
- Metoprolol Succinate ER (metoprolol)
- Nature's Bounty Probiotic (bifidobacterium infantis / lactobacillus acidophilus)
- Omega 3-6-9 Complex (omega-3 polyunsaturated fatty acids)
- Pepto-Bismol (bismuth subsalicylate)
- Peridex (chlorhexidine topical)
- Restasis (cyclosporine ophthalmic)
- Singulair (montelukast)
- Synthroid (levothyroxine)
- Ventolin HFA (albuterol)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xanax (alprazolam)
- Zofran (ondansetron)
Diphenhydramine/lidocaine/nystatin topical disease interactions
There are 5 disease interactions with diphenhydramine / lidocaine / nystatin topical which include:
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
